Steven E. Gregorich
University of California, San Francisco
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Steven E. Gregorich.
The Lancet | 2000
Thomas J. Coates; Olga Grinstead; Steven E. Gregorich; Kamenga Mc; Gloria Sangiwa; Donald Balmer; Colin Furlonge
The authors aim was to determine the efficacy of HIV-1 voluntary counseling and testing (VCT) in reducing unprotected intercourse among individuals and sex-partner couples in Nairobi (Kenya) Dar es Salaam (Tanzania) and Port of Spain (Trinidad). Individual or couple participants were randomly assigned HIV-1 VCT or basic health information. At first follow-up (mean 7.3 months after baseline) health-information participants were offered VCT and all VCT participants were offered retesting. Sexually transmitted infections were diagnosed and treated at first follow-up. The second follow-up (mean 13.9 months after baseline) involved only behavioral assessment and all participants were again offered VCT. 3120 individuals and 586 couples were enrolled. The proportion of individuals reporting unprotected intercourse with non-primary partners declined significantly more for those receiving VCT than those receiving health information (men 35% reduction with VCT vs. 13% reduction with health information; women 39% reduction with VCT vs. 17% reduction with health information) and these results were maintained at the second follow-up. Individual HIV-1-infected men were more likely than uninfected men to reduce unprotected intercourse with primary and non-primary partners whereas HIV-1-infected women were more likely than uninfected women to reduce unprotected intercourse with primary partners. Couples assigned VCT reduced unprotected intercourse with their enrolment partners significantly more than couples assigned health information but no differences were found in unprotected intercourse with non-enrolment partners. Couples in which one or both members were diagnosed with HIV-1 were more likely to reduce unprotected intercourse with each other than couples in which both members were uninfected. These changes were replicated by those in the health-information group diagnosed with HIV-1 at first follow-up. (authors)BACKGROUND Our aim was to determine the efficacy of HIV-1 voluntary counselling and testing (VCT) in reducing unprotected intercourse among individuals and sex-partner couples in Nairobi (Kenya), Dar es Salaam (Tanzania), and Port of Spain (Trinidad). METHODS Individual or couple participants were randomly assigned HIV-1 VCT or basic health information. At first follow-up (mean 7.3 months after baseline) health-information participants were offered VCT and all VCT participants were offered retesting. Sexually transmitted infections were diagnosed and treated at first follow-up. The second follow-up (mean 13.9 months after baseline) involved only behavioural assessment, and all participants were again offered VCT. FINDINGS 3120 individuals and 586 couples were enrolled. The proportion of individuals reporting unprotected intercourse with non-primary partners declined significantly more for those receiving VCT than those receiving health information (men, 35% reduction with VCT vs 13% reduction with health information; women, 39% reduction with VCT vs 17% reduction with health information), and these results were maintained at the second follow-up. Individual HIV-1-infected men were more likely than uninfected men to reduce unprotected intercourse with primary and non-primary partners, whereas HIV-1-infected women were more likely than uninfected women to reduce unprotected intercourse with primary partners. Couples assigned VCT reduced unprotected intercourse with their enrolment partners significantly more than couples assigned health information, but no differences were found in unprotected intercourse with non-enrolment partners. Couples in which one or both members were diagnosed with HIV-1 were more likely to reduce unprotected intercourse with each other than couples in which both members were uninfected. These changes were replicated by those in the health-information group diagnosed with HIV-1 at first follow-up. INTERPRETATION These data support the efficacy of HIV-1 VCT in promoting behaviour change.
Medical Care | 2006
Steven E. Gregorich
Comparative public health research makes wide use of self-report instruments. For example, research identifying and explaining health disparities across demographic strata may seek to understand the health effects of patient attitudes or private behaviors. Such personal attributes are difficult or impossible to observe directly and are often best measured by self-reports. Defensible use of self-reports in quantitative comparative research requires not only that the measured constructs have the same meaning across groups, but also that group comparisons of sample estimates (eg, means and variances) reflect true group differences and are not contaminated by group-specific attributes that are unrelated to the construct of interest. Evidence for these desirable properties of measurement instruments can be established within the confirmatory factor analysis (CFA) framework; a nested hierarchy of hypotheses is tested that addresses the cross-group invariance of the instruments psychometric properties. By name, these hypotheses include configural, metric (or pattern), strong (or scalar), and strict factorial invariance. The CFA model and each of these hypotheses are described in nontechnical language. A worked example and technical appendices are included.
The Lancet | 2000
Michael D. Sweat; Steven E. Gregorich; Gloria Sangiwa; Colin Furlonge; Donald Balmer; Claudes Kamenga; Olga Grinstead; Thomas J. Coates
BACKGROUND Access to HIV-1 voluntary counselling and testing (VCT) is severely limited in less-developed countries. We undertook a multisite trial of HIV-1 VCT to assess its impact, cost, and cost-effectiveness in less-developed country settings. METHODS The cost-effectiveness of HIV-1 VCT was estimated for a hypothetical cohort of 10000 people seeking VCT in urban east Africa. Outcomes were modelled based on results from a randomised controlled trial of HIV-1 VCT in Tanzania and Kenya. Our main outcome measures included programme cost, number of HIV-1 infections averted, cost per HIV-1 infection averted, and cost per disability-adjusted life-year (DALY) saved. We also modelled the impact of targeting VCT by HIV-1 prevalence of the client population, and the proportion of clients who receive VCT as a couple compared with as individuals. Sensitivity analysis was done on all model parameters. FINDINGS HIV-1 VCT was estimated to avert 1104 HIV-1 infections in Kenya and 895 in Tanzania during the subsequent year. The cost per HIV-1 infection averted was US
AIDS | 2001
Olga Grinstead; Steven E. Gregorich; Kyung-Hee Choi; Thomas D. Coates
249 and
Social Science & Medicine | 2013
Belinda L. Needham; Nancy E. Adler; Steven E. Gregorich; David H. Rehkopf; Jue Lin; Elizabeth H. Blackburn; Elissa S. Epel
346, respectively, and the cost per DALY saved was
Journal of Acquired Immune Deficiency Syndromes | 2007
Kyung-Hee Choi; Zhen Ning; Steven E. Gregorich; Qi-chao Pan
12.77 and
Health Psychology | 1997
Barbara VanOss Marin; Cynthia A. Gómez; Jeanne M. Tschann; Steven E. Gregorich
17.78. The intervention was most cost-effective for HIV-1-infected people and those who received VCT as a couple. The cost-effectiveness of VCT was robust, with a range for the average cost per DALY saved of
American Journal of Public Health | 2004
Karin K. Coyle; Douglas Kirby; Barbara VanOss Marin; Cynthia A. Gómez; Steven E. Gregorich
5.16-27.36 in Kenya, and
Obstetrics & Gynecology | 2006
Miriam Kuppermann; Lee A. Learman; Elena Gates; Steven E. Gregorich; Robert F. Nease; James Lewis; A. Eugene Washington
6.58-45.03 in Tanzania. Analysis of targeting showed that increasing the proportion of couples to 70% reduces the cost per DALY saved to
Journal of Applied Psychology | 1990
Steven E. Gregorich; Robert L. Helmreich; John A. Wilhelm
10.71 in Kenya and